Latest News for: paraganglioma

Edit

Merck's WELIREG Entry Brings New Momentum to Pheochromocytomas and Paragangliomas Therapeutics Market | DelveInsight

PR Newswire 28 May 2025
The FDA has granted a third approval for WELIREG, authorizing its use as a treatment for patients with rare endocrine system tumors known as pheochromocytoma or paraganglioma (PPGL) ... Paragangliomas.
  • 1
×